Correlation Between Novacyt SA and Aethlon Medical

Can any of the company-specific risk be diversified away by investing in both Novacyt SA and Aethlon Medical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Novacyt SA and Aethlon Medical into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Novacyt SA and Aethlon Medical, you can compare the effects of market volatilities on Novacyt SA and Aethlon Medical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Novacyt SA with a short position of Aethlon Medical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Novacyt SA and Aethlon Medical.

Diversification Opportunities for Novacyt SA and Aethlon Medical

-0.04

Correlation Coefficient

Novacyt SA  Aethlon Medical

Good diversification

The 3 months correlation between Novacyt and Aethlon is -0.04. Overlapping area represents the amount of risk that can be diversified away by holding Novacyt SA and Aethlon Medical in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Aethlon Medical and Novacyt SA is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Novacyt SA are associated (or correlated) with Aethlon Medical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Aethlon Medical has no effect on the direction of Novacyt SA i.e., Novacyt SA and Aethlon Medical go up and down completely randomly.

Pair Corralation between Novacyt SA and Aethlon Medical

Assuming the 90 days horizon Novacyt SA is expected to under-perform the Aethlon Medical. But the pink sheet apears to be less risky and, when comparing its historical volatility, Novacyt SA is 2.59 times less risky than Aethlon Medical. The pink sheet trades about -0.12 of its potential returns per unit of risk. The Aethlon Medical is currently generating about 0.08 of returns per unit of risk over similar time horizon. If you would invest  47.00  in Aethlon Medical on September 30, 2024 and sell it today you would earn a total of  14.00  from holding Aethlon Medical or generate 29.79% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Novacyt SA  vs.  Aethlon Medical

Novacyt SA

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Novacyt SA has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unfluctuating performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders.

Aethlon Medical

Risk-Adjusted Performance

6 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Aethlon Medical are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of rather inconsistent primary indicators, Aethlon Medical exhibited solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Novacyt SA and Aethlon Medical

The main advantage of trading using opposite Novacyt SA and Aethlon Medical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Novacyt SA position performs unexpectedly, Aethlon Medical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aethlon Medical will offset losses from the drop in Aethlon Medical's long position.

The idea behind Novacyt SA and Aethlon Medical pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stocks Directory module to find actively traded stocks across global markets.